A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia.

Center for Cognitive Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Schizophrenia Research (Impact Factor: 4.43). 06/2009; 113(2-3):167-75. DOI: 10.1016/j.schres.2009.04.020
Source: PubMed

ABSTRACT The severity and profile of cognitive dysfunction in first episode schizophrenia and psychotic affective disorders were compared before and after antipsychotic treatment. Parallel recruitment of consecutively admitted study-eligible first-episode psychotic patients (30 schizophrenia, 22 bipolar with psychosis, and 21 psychotic depression) reduced confounds of acute and chronic disease/medication effects as well as differential treatment and course. Patient groups completed a neuropsychological battery and were demographically similar to healthy controls (n=41) studied in parallel. Prior to treatment, schizophrenia patients displayed significant deficits in all cognitive domains. The two psychotic affective groups were also impaired overall, generally performing intermediate between the schizophrenia and healthy comparison groups. No profile differences in neuropsychological deficits were observed across patient groups. Following 6 weeks of treatment, no patient group improved more than practice effects seen in healthy individuals, and level of performance improvement was similar for affective psychosis and schizophrenia groups. Although less severe in psychotic affective disorders, similar profiles of generalized neuropsychological deficits were observed across patient groups. Recovery of cognitive function after clinical stabilization was similar in mood disorders and schizophrenia. To the extent that these findings are generalizable, neuropsychological deficits in psychotic affective disorders, like schizophrenia, may be trait-like deficits with persistent functional implications.

  • [Show abstract] [Hide abstract]
    ABSTRACT: It is well known that patients with bipolar disorder (BD) have cognitive impairments even during periods of euthymia. However, to date it remains unclear the moment when these deficits onset. Therefore, the aim of this study was to review the evidence focusing on the cognitive status of patients with BD in their premorbid stage and in their first episode. An extensive search was conducted through the online databases Pubmed/PsychInfo, covering the period between 1980 and 2014. A total of 23 studies were selected for the review (nine studies explored premorbid stage of people who lately develop BD and 14 examined first-episodes in bipolar patients). There is evidence that general intelligence is not impaired in the premorbid stage. Impairments in verbal memory, attention, and executive functions tend to be present during and after the first episode. Preliminary evidence suggests that these deficits in specific cognitive domains might precede the onset of illness. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
    Psychiatry Research 01/2015; 226(1). DOI:10.1016/j.psychres.2014.12.044 · 2.68 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aim: Improved approaches to remediate cognitive deficits are needed. The aim of this study was to investigate the effects of a novel cognitive remediation (CR) game in first episode psychosis (FEP). Methods: Participants were 11 FEP clients in two treatment arms; CR and Treatment as Usual (TAU). Baseline assessments included pre-morbid IQ, symptoms and neurocognition. The CR group had 8 sessions of therapy in a group setting with the control group receiving TAU. Post intervention groups were re-assessed for symptoms and cognitive function. Results: There were no significant differences between groups at baseline in symptoms or cognitive function. Post intervention significant improvements were observed in negative symptoms and executive function along with a significant relationship between negative symptoms and executive function in the CR group. Conclusions: These data, from a small sample, suggest that X-Cog could form part of an effective strategy to remediate cognitive deficits.
    (Psychosis) Psychological, Social and Integrative Approaches 10/2013; 6(3):215-219. DOI:10.1080/17522439.2013.791876 · 1.00 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cognitive deficits have been well-established among patients with severe mental illness. The aim of this study was to clarify the patterns of cognitive deficits in drug-naive patients with schizophrenia and non-psychotic major depressive disorder (MDD) as compared with controls. Thirty drug-naïve participants with schizophrenia, 30 counterparts with non-psychotic MDD, and 30 age-, sex-, and education years-matched healthy controls were recruited. Neuropsychological tests, including the Wisconsin Card Test (WCST), the Continuous Performance Test (CPT) and the Finger Tapping Test (FTT), were administered. Patients with schizophrenia performed more poorly than the patients with MDD and the normal controls in the WCST. The patients with schizophrenia and the patients with MDD both performed more poorly than the normal controls in the CPT. The patients with MDD also performed more poorly than the normal controls in the FTT. The age of onset of MDD in this study was younger than in previous reports. The cross-sectional design, small sample sizes, and limited numbers of neuropsychological domains in this study are all obstacles to making a clear causal conclusion. These results revealed a distinct pattern of neurocognitive dysfunction among drug-naive patients with schizophrenia and MDD, which may imply different underlying neurobiological mechanisms in schizophrenia and MDD. Copyright © 2015 Elsevier B.V. All rights reserved.
    Journal of Affective Disorders 01/2015; 175C:133-138. DOI:10.1016/j.jad.2014.12.059 · 3.71 Impact Factor

Full-text (2 Sources)

Available from
Jun 4, 2014